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Formation of a Highly Peptide-Receptive
State of Class II MHC
detergent-solubilized class II molecules from B cell
lines. These studies found that antigenic peptides bind
to purified class II molecules to form stable complexes,
Joshua D. Rabinowitz,* Marija Vrljic,*
Peter M. Kasson,* Michael N. Liang,*
Robert Busch,² J. Jay Boniface,³
but that this binding is very slow (kon ≈ 1±100 M21 s21)Mark M. Davis,³ and Harden M. McConnell*§
(Buus et al., 1986; Roche and Cresswell, 1990; Roof et*Department of Chemistry
al., 1990). It was later found that these B cell±derived²Department of Pediatrics
class II molecules contain a diverse array of endogenous³Howard Hughes Medical Institute
peptides (Buus et al., 1988), and that the dissociationStanford University
of these endogenous peptides limits the rate of labeledStanford, California 94305
peptide association (Tampe and McConnell, 1991; Reay
et al., 1992; Witt and McConnell, 1993). Expression of
recombinant MHC lacking the transmembrane domainSummary
allowed purification of water-soluble class II molecules
devoid of endogenous peptide (Wettstein et al., 1991;Peptide binding to class II MHC proteins occurs in
Stern and Wiley, 1992). Compared to detergent-solubi-acidic endosomal compartments following dissocia-
lized class II±containing endogenous peptides, this wa-tion of class II±associated invariant chain peptide
ter-soluble protein binds peptide slightly more rapidly(CLIP). Based on peptide binding both to empty class
(kon ≈ 10±100 M21 s21). Nevertheless, this associationII MHC and to molecules preloaded with peptides in-
rate is approximately 105-fold slower than that of ancluding CLIP, we find evidence for two isomeric forms
analogous peptide±protein reaction, the folding of theof empty MHC. One (inactive) does not bind peptide.
protein RNaseS (Goldberg and Baldwin, 1998), and isThe other (active) binds peptide rapidly, with kon 1000-
104-fold slower than a recent measurement of peptidefold faster than previous estimates. The active isomer
binding to class I MHC (Springer et al., 1998).can be formed either by slow isomerization of the in-
It has been suggested that the slow association rateactive molecule or by dissociation of a preformed
of peptide to class II protein may be related to complex-peptide/MHC complex. In the absence of peptide, the
ity in the peptide/class II reaction pathway (Sadegh-active isomer is unstable, rapidly converting to the
Nasseri and McConnell, 1989; Sadegh-Nasseri et al.,inactive isomer. These results demonstrate that fast
1994). In particular, it has been proposed that a peptidepeptide binding is an inherent property of one isomer
may rapidly bind to class II MHC to form an unstable,of empty class II MHC. Dissociation of peptides such
kinetic intermediate complex which slowly converts intoas CLIP yields this transient, peptide-receptive isomer.
the stable, terminal complex observed in typical peptide
binding assays. In this proposal, the kinetic intermediateIntroduction
and terminal complexes are isomers, molecular com-
plexes identical in covalent structure (peptide sequenceClass II MHC genes encode heterodimeric membrane
and covalent modifications) but with different three-glycoproteins that bind peptides and present them to
dimensional structure and reaction rates. The kineticCD41 T cells. The predominant pathway that generates
intermediate proposal is supported by the observationpeptide/class II MHC complexes begins with the assem-
that a single peptide can bind to a single MHC proteinbly of newly synthesized class II MHC with another mem-
to form two isomeric complexes (Sadegh-Nasseri andbrane protein, invariant chain (Ii), in the endoplasmic
McConnell, 1989; Beeson and McConnell, 1994; Sa-reticulum. Complexes of class II and Ii assembled in the
degh-Nasseri et al., 1994; Witt and McConnell, 1994;ER traverse the Golgi apparatus to endosomal compart-
Tompkins et al., 1996; Rabinowitz et al., 1997). However,ments where Ii is proteolyzed (reviewed in Pieters, 1997;
it is unclear whether these kinetic isomers are the pri-Chapman, 1998). Following proteolysis of Ii, a set of
mary reason for the slow apparent association rate ofpeptides derived from residues 81±104 of Ii (class II±
peptide to purified class II.associated invariant chain peptides [CLIP]) remains
To understand better the reasons for this slow ap-bound to class II, filling the antigenic peptide binding
parent rate, we have made a detailed kinetic study ofcleft (Ghosh et al., 1995; Lee and McConnell, 1995; Sette
peptide binding to water-soluble I-Ek derived fromet al., 1995). Dissociation of CLIP results in class II MHC
transfected Chinese hamster ovary cells (sEk) (Wettsteinheterodimers that bind antigenic peptides or other self-
et al., 1991). Unlike several other empty class II mole-peptides present in the endocytic system. CLIP dissoci-
cules (Stern and Wiley, 1992; Germain and Rinker, 1993),ation is accelerated by another membrane protein, HLA-
empty sEk does not rapidly form aggregates. Further-DM (Denzin and Cresswell, 1995; Sherman et al., 1995;
more, the circular dichroism spectrum of sEk closelySloan et al., 1995).
resembles that of peptide-loaded I-Ek (Reich et al.,One approach to understanding peptide binding to
1997), suggesting the empty sEk is folded similarly toclass II MHC is to mix purified class II MHC with labeled
the peptide-loaded molecule (Fremont et al., 1996).peptides and measure peptide/MHC complex forma-
Experiments measuring the binding of labeled peptidetion. Initial studies of this type were performed using
to empty versus peptide-loaded sEk provide evidence
for two distinct isomers of empty sEk, a less stable ac-§ To whom correspondence should be addressed (e-mail: harden@
leland.stanford.edu). tive isomer and a more stable inactive isomer. Inactive
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Assuming this reaction scheme, dissociation of pre-
bound peptide will likely, based on the principle of mi-
croscopic reversibility (Fersht, 1985), leave sEk in the
active state. To investigate this possibility, we measured
the binding of labeled MCC peptide to several preformed
peptide/MHC complexes. In each case, the rate of la-
beled peptide binding is approximately equal to the rate
of dissociation of the preformed complex (Figure 2),
suggesting that dissociation of the preformed peptide/
MHC complex is followed by rapid association of the
second peptide (scheme 2).
Figure 1. The Rate of Antigenic Peptide Binding to Empty sEk Is
Not Accelerated by Increasing the Concentration of Added Peptide
The indicated concentration of fluorescently labeled MCC Ac95-103
was reacted with 100 nM {sEk}0 at pH 5.3, 378C. After the indicated The most rapid binding of labeled MCC (.50-fold faster
time, free peptide was separated from peptide/MHC complex by
than binding to {sEk}0) is observed when CLIP/sEk issize exclusion chromatography, and labeled peptide/MHC complex
used as the starting material, consistent with the rapidformation was measured by a fluorescence detector.
dissociation of CLIP from sEk (Figure 2A). Such acceler-
ation of the peptide binding reaction is not specific todoes not bind peptide, while active binds peptide rap-
CLIP, as the peptide corresponding to the C-terminalidly. The slow apparent rate of peptide binding to empty
eight amino acids of MCC (8-mer) is also effective insEk is due to slow isomerization of inactive into active.
promoting rapid loading with labeled peptide (Figure 2C).This slow step is bypassed when CLIP-loaded sEk is
used as the starting material, because CLIP dissociation
Reversible Inactivation of Active sEkreleases the active isomer. The generality of this reaction
The reactions of active sEk formed by peptide dissocia-scheme is supported by studies of labeled peptide bind-
tion were investigated by allowing either CLIP or 8-mering to water-soluble DR1 (sDR1), and also of T cell stimu-
peptide to dissociate in the absence of added peptidelation by I-Ek on the surface of a fixed APC (see Appen-
for various lengths of time (ªdelay timesº). The amountdix 2). Together these findings suggest that active and
of active sEk present after the delay was measuredinactive isomers may be a general feature of class II
based on the binding of labeled MCC for 5 min. TheMHC, and that a previously unrecognized function of
amount of active sEk increased at early times as 8-mer/CLIP is to promote endosomal peptide binding by re-
sEk (Figure 3A) or CLIP/sEk (data not shown) dissoci-lease of the active isomer.
ated. After 10 min, however, the fraction of active mate-
rial decreased, consistent with inactivation of the activeResults
sEk, with the active material having a half-life of 13
min at pH 5.3, 378C (see Experimental Procedures forDissociation of a Prebound Peptide
details). The inactivation of sEka was reversible, as addi-Generates Active sEk
tion of labeled MCC to inactivated sEk (sEki) resultedWe studied the reaction of the antigenic peptide moth
in slow accumulation of labeled MCC/Ek complex untilcytochrome c Ac95-103 (MCC) with sEk that was purified
most sEk was filled (Figure 3B). Like the reaction be-from cells by affinity and size exclusion chromatography
tween {sEk}0 and peptide, the reaction between sEki andand stored at pH 7, 48C until use. We use the symbol
peptide is not accelerated by adding peptide concentra-{sEk}0 to represent this initial ensemble of sEk molecules.
tions .100 nM (data not shown). Consistent with sEkiConsistent with previous reports (Reay et al., 1992), we
and {sEk}0 both representing a similar, steady-state formfind that the binding of MCC to sEk is essentially irrevers-
of empty class II, incubation of {sEk}0 overnight in theible (dissociation t1¤2 at pH 5.3±7.0, 378C .200 hr), and
absence of added peptide at pH 5.3 or pH 7.0, 378Cthat binding of MCC to {sEk}0 slowly proceeds until most
does not result in substantial (.10%) sEk aggregationsEk is peptide bound. In addition, we find that the rate
or a substantial change in peptide binding kinetics (dataof peptide binding to {sEk}0 is nearly independent of the
not shown).MCC peptide concentration for [MCC] . 100 nM at pH
In combination, these results support the following5.3 (Figure 1) (Note: the reaction at pH 7.0 is much slower
reaction pathway for sEk (scheme 3):and requires micromolar peptide concentrations; see
Appendix 1). One simple interpretation of this result is
that peptide binding is preceded by a peptide-indepen-
dent reaction of molecules in {sEk}0 to form active sEk
(sEka) (scheme 1).
Since sEki and sEka reversibly interconvert, there is
no possibility that sEki simply reflects sEk loaded with
endogenous peptide. These interconversions occur in
the absence of an energy source, and thus sEki and
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sEka are isomers with identical covalent structure. A
potential complication to this reaction scheme is that
the slow peptide binding to both sEki and {sEk}0 is better
described by a sum of two exponential binding curves
than a single exponential curve, indicating there may be
more than one isomer of inactive sEk (data not shown).
Association Rate of Different Peptides
to Active sEk
The ability to generate a sample containing a significant
fraction of active, empty sEk (z25%) by dissociation of
the 8-mer/sEk complex for 5 min in the absence of added
peptide allowed direct measurement of the rate of la-
beled peptide binding to active sEk (Figure 4). The rate
of peptide binding was determined in two ways, either
by measuring the peptide concentration dependence of
binding over a fixed time interval (3 min, Figure 4), or
by measuring the time dependence of binding of a fixed
concentration of peptide (data not shown). In both
cases, the results are consistent with reaction scheme
(3), with a rate of peptide binding of z5 3 105 M21 s21
found for the MCC 95-103 peptide, CLIP, and a CLIP
mutant in which the P1 and P9 methionine anchor resi-
dues have been replaced by leucine. This association
rate is z4 3 103-fold faster than previous estimates
of the peptide-{sEk}0 association rate. In addition, it is
interesting to note that the different peptides studied all
bind with very similar association rate constants despite
varying in their dissociation rates by .103-fold (dissocia-
tion t1¤2 . 200 hr for MCC versus 3 min for CLIP; Figure
2 and Reay et al., 1992; Liang et al., 1995). To confirm
that these brief reactions of MCC with active sEk do
indeed produce stable complexes, we measured the
dissociation rate of complexes formed in this way. We
find that most such complexes are stable, with ,20%
dissociating in 24 hr at pH 5.3, 378C (data not shown).
Dissociation of Prebound Peptide
Generates Active sDR1
To investigate whether reaction scheme (3) might also
apply to other class II MHC molecules, we studied the
rate of peptide binding to empty sDR1 purified from
transfected insect cells (Stern and Wiley, 1992; Sloan
et al., 1995), frozen, and thawed immediately before
use ({sDR1}0). Unlike sEk, empty sDR1 forms oligomers
(Stern and Wiley, 1992); therefore, reaction scheme (3)
is an incomplete description of its reactions. However,
similar to sEk, sDR1 preloaded with a rapidly dissociat-
ing peptide (8-mer) binds peptide more rapidly than
{sDR1}0. Moreover, lower concentrations of antigenic
peptide (hemagglutinin 306±318, HA) are required to
achieve maximal binding to 8-mer/sDR1 complex than
Figure 2. Dissociation of a Preformed Peptide/MHC Complex Gen-
erates Active sEk
In each panel, the starting material is 50 nM of the complex between
sEk and the peptide indicated in bold on the panel. The filled circles slightly faster than peptide dissociation. This is likely because the
indicate complex dissociation; the open circles, association of 5 unlabeled 8-mer peptide dissociates slightly faster than the labeled
mM labeled MCC Ac95-103. The dissociation axis represents the 8-mer peptide, presumably due to a hydrogen bond between the
fraction of the initial complex remaining; the association axis, the label and the MHC protein predicted based on the I-Ek crystal struc-
fraction of total sEk bound by MCC. Both association and dissocia- ture (Fremont et al., 1996). Also in (C), the association axis extends
tion are at pH 5.3, 378C. Solid lines are a single-exponential fit to only to 0.6 units, because only half of the sEk produced by 8-mer
the plotted data. For comparison to these data, peptide binding to dissociation is highly peptide receptive. (D) is a negative control
{sEk}0 is only 1/3 complete after 120 min, the latest time shown in which shows that a stable preformed peptide/MHC complex will
this figure (see Figure 1). In (C), peptide association appears to be not bind the added labeled peptide.
Immunity
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Figure 4. Rapid Binding of Several Different Peptides to Active sEk
A solution containing approximately 25% active sEk (total sEk con-
centration 8 nM) was formed by allowing 8-mer/sEk complex to
dissociate in the absence of added peptide for 5 min at pH 5.3,
378C. At this point, the labeled peptide indicated in the figure legend
was added and allowed to bind for 3 min. Lines indicate a single
exponential fit to the data with kon ≈ 5 3 105 M21 s21 (range 4±6 3
105 M21 s21) for each peptide (see Experimental Procedures).
be greater than the rate of sDR1a inactivation (for details,
Figure 3. Reversible Inactivation of Active sEk see Experimental Procedures).
(A) Formation of active sEk by peptide/MHC complex dissociation It has been previously reported that 100 mM HA pep-
is followed by rapid sEk inactivation. 8-mer/sEk complex was incu- tide binds to {sDR1}0 rapidly but forms unstable com-
bated at pH 5.3 and 378C for the indicated ªdelay timeº in the ab- plexes (Sadegh-Nasseri et al., 1994). We measured the
sence of added peptide. The amount of active sEk present after the
stability of the HA/sDR1 complexes formed by reactiondelay was measured by the binding of 5 mM labeled MCC for 5
of labeled HA (1 mM) with 8-mer/sDR1 complex (100 nM)min. The solid line indicates the analytical solution to the system of
for 20 min. In association reactions at either pH 7.0 ordifferential equations describing reaction scheme (3) (see Experi-
mental Procedures), with the half-life of active sEk of 13 min. Errors pH 5.3, only slow dissociating complexes are formed,
bars indicate the standard error of triplicate measurements after with ,4% of the complex dissociating in 24 hr at 378C
delays of 10 min and 40 min. at either pH (data not shown). In comparison to the work
(B) Inactive sEk slowly reverts to active sEk. Shaded bars depict
of Sadegh-Nasseri et al. (1994), our measurements usedthe binding of labeled MCC to inactive sEk formed by incubating
a lower peptide concentration, high performance sizeCLIP/sEk complex in the absence of peptide for 2 hr at pH 5.3,
exclusion chromatography instead of spin columns, and378C prior to the MCC addition. Solid bars are the positive control
depicting the binding of labeled MCC to CLIP/sEk complex. CLIP/ HA peptide labeled with carboxyfluorescein on the N
sEk is at 50 nM; labeled MCC at 100 nM; similar data have been terminus instead of with 125I on the P1 tyrosine residue.
obtained for MCC concentrations up to 50 mM. Error bars indicate This tyrosine is the most important MHC contact of the
the standard error of duplicate measurements.
HA peptide (Stern et al., 1994).
Discussionto {sDR1}0 (Figures 5A and 5B). This suggests that sDR1,
like sEk, exists in multiple empty states, one of which,
sDR1a, binds peptide rapidly. Similar to sEka, sDR1a is In this report we deduce the existence of two isomers
of empty class II MHC that have very different peptideunstable, losing the ability to bind peptide with a half-
time of approximately 5 min (Figure 5C). The rate of binding capacities. One isomer (active) binds peptide
rapidly at endosomal pH (kon ≈ 105 M21 s21). The othersDR1a inactivation is not strongly dependent on sDR1
concentration, suggesting that the rate-limiting step in isomer (inactive) does not itself bind peptide but can
slowly (t1¤2 ≈ 3 hr) isomerize into the active molecule. Inthe inactivation reaction is not aggregation but isomer-
ization. the absence of peptide, the active isomer is unstable,
inactivating with a half-time of a few minutes. TheseBecause 8-mer dissociation from sDR1 is slower than
the inactivation of sDR1a, it is not possible to accumu- isomers appear to be a general feature of I-Ek, as they
are formed both by a water-soluble version of the I-Eklate a substantial pool of sDR1a by 8-mer dissociation.
Therefore, the association rate for peptide binding to protein (sEk) and by I-Ek on the surface of a fixed B
lymphoma cell (see Appendix 2). In addition, the peptidesDR1a cannot be directly measured, as it was for sEka.
The rate can, however, be approximated based on the binding characteristics of water-soluble DR1, although
complicated by oligomerization, are consistent with anminimal concentration of HA required to fill most sDR1a
formed by 8-mer dissociation (100 nM HA, Figure 5B). active DR1 isomer.
The isomerization reactions of empty class II MHCThis approximation, which gives kon ≈ 3 3 104 M21 s21,
is based on assumption that effective filling of sDR1a are a notable example of how the activity of a protein
can be controlled by its folding kinetics. In many cases,requires that the rate of peptide binding, kon [p], must
Isomers of Empty Class II MHC
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Figure 5. Dissociation of a Preformed Peptide/sDR1 Complex Generates Active sDR1
(A) Binding of the indicated concentration of fluorescently labeled influenza hemagglutinin 306-318 peptide (HA) to 100 nM {sDR1}0 at pH 5.3
and 378C.
(B) Binding of the indicated concentration of HA to preformed 8-mer/sDR1 complex (50 nM) at pH 5.3 and 378C. 8-mer is MCC Ac96-103.
(C) Formation of active sDR1 (sDR1a) by peptide/MHC complex dissociation is followed by rapid sDR1 inactivation. The indicated concentration
of 8-mer/sDR1 complex was incubated at pH 5.3, 378C for the indicated ªdelay timeº in the absence of added peptide. The amount of active
sDR1 present after the delay was measured by the binding of 1 mM labeled HA for 5 min. The solid line indicates the analytical solution to
the system of differential equations describing reaction scheme (3) (see Experimental Procedures), with the half-life of active sDR1 of 4 min
for the 17 nM sDR1 and 6 min for the 50 nM sDR1.
proteins fold rapidly to a single state that performs the suggests that the transition state is high in both entropy
and enthalpy.function of the protein. This state may represent the
thermodynamic global minimum for a particular protein An intriguing question is whether protein isomeriza-
tion is biologically useful. In the case of the prions, isom-covalent structure. In other cases, intermediates in the
protein folding pathway may persist for a long enough erization of the native state into the prion form appears
to be a disadvantage. In the case of the serpins, how-time to be biologically relevant (Baker and Agard, 1994).
One important instance of such folding is the isomeriza- ever, it is unclear whether the irreversible inactivation
reaction is merely a result of intrinsic protein instabilitytion of normal proteins into prions (reviewed in Harrison
et al., 1997). Another well-studied example is the folding or whether it is of value as a regulatory mechanism. For
class II molecules, arguments can be made for eitherof the serpin family of protease inhibitors. Some serpins,
such as plasminogen activator inhibitor 1, fold first to a viewpoint. On the one hand, removal of the peptide from
the crystal structure of peptide/MHC complexes wouldstate that is an active protease inhibitor (Wang et al.,
1996). This active isomer then converts to a more stable, result in a potentially unstable structure, with a cleft
between the a helices and exposed hydrophobic pock-but inactive, isomer over a period of several hours. Re-
version of the stable, inactive isomer to the less stable, ets (Stern et al., 1994; Ghosh et al., 1995; Fremont et
al., 1996). This raises the possibility that the inactivationactive isomer has not been observed. Analogous to the
serpins, empty class II MHC folds into two isomers, with of the peptide-receptive state of empty class II MHC
may be an inevitable consequence of the general foldthe less stable isomer performing the peptide binding
function of the protein. In contrast to the serpins, how- of the protein. On the other hand, it is possible that the
general fold of MHC has been evolutionarily selected inever, the isomers of empty class II reversibly intercon-
vert. Based on the rates of interconversion, the free part because the instability of empty, active MHC is
advantageous. One effect of reversible MHC inactivationenergy difference between the isomers is approximately
2 kcal/mol. Experiments measuring the temperature de- is to maintain a steady but low number of active cell
surface binding sites (see Appendix 2). This may pro-pendence of the rate of sEk isomerization have been
performed to investigate the enthalpy and entropy of mote immune surveillance while preventing the binding
of large numbers of self-peptides against which toler-the transition state in this reaction (J. R., Gordana Kon-
jevic, and H. M. M., unpublished results). The finding that ance is weak or not established.
Regulation by accessory molecules may enhance thethis rate decreases greatly with decreasing temperature
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advantageous aspects of protein isomerization reac-
tions while minimizing their negative consequences. At
least two accessory molecules, invariant chain (Ii) and
HLA-DM, are required for the normal function of class
II MHC (Bikoff et al., 1993; Viville et al., 1993; Karlsson
et al., 1994; Morris et al., 1994). Ii binds to newly synthe-
sized class II MHC in the endoplasmic reticulum and
remains bound until the Ii/class II MHC complex reaches
the endosome. There, Ii is proteolyzed to CLIP, and CLIP
release is catalyzed by HLA-DM, which remains bound
to empty class II MHC preventing its inactivation and
aggregation (Denzin et al., 1996; Kropshofer et al., 1997).
We propose that the precise effect of HLA-DM is to
prevent the isomerization of active class II MHC to the
inactive state. This proposal is consistent with Krop-
shofer et al.'s data showing that in the absence of HLA-
DM the loss of class II peptide binding capacity occurs
before the accumulation of aggregated MHC (compare
Figures 1A and 3C of Kropsofer et al., 1997) and that
this loss of peptide binding capacity is prevented by
HLA-DM.
In addition to peptide binding to newly synthesized
class II MHC as described above, peptide can also bind
to recycled MHC via an alternative pathway independent
of Ii and DM (Pinet et al., 1995; Zhong et al., 1997).
Peptide epitopes processed in late endosomes are pre-
sented via the Ii- and DM-dependent pathway; epitopes
Figure 6. Reactions of sEk at pH 7.0processed in early endosomes are presented via the
(A) Dissociation of a preformed peptide/sEk complex generates ac-recycling pathway. A common feature of both pathways
tive sEk. Analogous to Figure 2B, starting material is 50 nM of theis that binding of antigenic peptide follows dissociation
complex between sEk and CLIP M90L M98L. The filled circles indi-of a prebound peptide. Therefore, our finding that disso-
cate complex dissociation; the open circles, the association of 5
ciation of a prebound peptide releases an active state
mM labeled MCC Ac95-103. Solid lines are a single-exponential fit
of class II MHC provides a common mechanism for the to the plotted data. For comparison, 5 mM MCC Ac95-103 binding
effective loading of class II in both cases. The active to empty {sEk}0 is shown as the open squares and dashed line.
(B) Peptide concentration dependence of sEka binding at pH 7.0.state of class II MHC binds a diverse array of peptides
The indicated concentration of fluorescently labeled MCC Ac95-103with a similar, rapid association rate (Figure 4). This
was reacted with 100 nM CLIP M90L M98L/sEk complex at 378C, andproperty should facilitate the generation of a diverse
the binding after 20 min was compared to the binding of saturating
repertoire of peptide/MHC complexes that is restricted concentrations of labeled MCC (100±300 mM).
solely by the set of peptides present when the active
class II isomer is formed and by the stability of the
that are class II restricted and peptide specific (Rabin-resulting complexes.
owitz et al., 1996). The kinetics of the T cell response
reflect the kinetics of the reactions of peptide with cellAppendix 1: Reactions of Soluble Class II
surface class II (McConnell et al., 1995; Beeson et al.,MHC at pH 7.0
1996; Rabinowitz et al., 1997). Thus, APCs must have aConsistent with previous work (Wettstein et al., 1991;
pool of active, empty class II molecules on their surfaceReay et al., 1992; Sette et al., 1992; Boniface et al., 1993),
that can be rapidly loaded with peptide to stimulate Twe do not observe any major pH effect on the reactions
cells. We have undertaken experiments aimed at under-of sDR1, but we do find that peptide binding to sEk is
standing the source of this pool of empty, cell surfacemuch more rapid at acidic than neutral pH (compare
class II. In addition, these experiments were designedFigure 2 and Figure 6A). One common feature of peptide
to investigate whether our reaction scheme for sEkbinding to empty sEk at pH 7.0 and pH 5.3 is that dissoci-
could be generalized to cell surface I-Ek.ation of a preformed peptide/sEk complex results in
Our experimental approach was to manipulate cellactive sEk (Figures 2 and 6A). The slower rate of peptide
surface I-Ek by preloading it with nonantigenic peptidesbinding to {sEk}0 at pH 7.0 reflects that both the associa-
that bind either transiently or stably, and thus mighttion rate of peptide to active sEk (Figure 4 versus 6B)
either enhance or inhibit subsequent binding of anti-and the isomerization of inactive to active sEk (t1¤2 ≈ 3
genic peptide. The binding of the antigenic peptide MCChr at pH 5.3 versus t1¤2 ≈ 26 hr at pH 7.0, Figure 1 and
was measured by the acid release of MCC-specific Tdata not shown) are slower at pH 7.0 than at pH 5.3.
cells. Preliminary experiments using live CH27 B lym-
phoma cells as APCs did not reveal any substantialAppendix 2: Reactions of Cell Surface I-Ek
effect of preloading the APCs with different peptides.as Measured by T Cell Stimulation
This likely reflects both the rapid turnover of the I-Ek onExposure of a mixture of T cells and APCs to antigenic
peptide results in rapid increases in T cell acid release the live CH27 cell surface and the difficulty of effectively
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loading I-Ek at neutral pH. To avoid these problems, we surface as measured by the T cell activation dose re-
sponse (Figure 7C and data not shown). In four indepen-simplified the system by fixing the CH27 cells. Fixing
the APCs resulted in an approximately 2-fold increase dent experiments this decrease was always $3-fold,
indicating that the half-life of the active, cell surface I-Ekin the concentration of MCC peptide required to produce
a given T cell response (data not shown). Such shifts in must be ,40 min.
The experiments described above demonstrate thatthe T cell dose response likely reflect reciprocal changes
in the amount of active I-Ek on the APC surface, based active I-Ek on the cell surface is unstable, but that incu-
bating freshly fixed APCs in the absence of peptide doeson the equation
not markedly reduce the amount of active I-Ek on their
[p/Ek] 5 kon ´ t ´ [p] ´ [Eka] (I) surface. Together these findings suggest that much of
the active I-Ek on the cell surface is produced by reacti-
where [p/Ek] is the number of peptide/I-Ek complex on vation of inactive, empty I-Ek. However, an alternative
the APC surface, [p] the concentration of peptide in possibility is reactivation of cell surface I-Ek does not
solution, and [Eka] the number of active I-Ek molecules occur, and that the steady level of active I-Ek on the
on the APC surface. This equation is valid when the APC surface is due soley to slow release of endogenous
product kon ´ t ´ [p] ,, 1 (i.e., when peptide binding peptide. The final set of APC preloading experiments
does not begin to saturate Eka). In our T cell stimulation was designed to test these possibilities. The approach in
experiments, #3 mM peptide is added for 3 min at pH these experiments was to reduce the amount of empty,
7.0, satisfying these criteria (Figure 6B). Before preload- inactive I-Ek on the cell surface and see whether this
ing the fixed CH27 cells with peptide, we wanted to test would affect the amount of active I-Ek present. If a sub-
whether leaving the APCs at pH 5.3, 378C in the absence stantial fraction of active I-Ek is formed by reactivation
of peptide would affect their ability to present peptide of inactive, empty molecules, then a decrease in active
antigen. In these experiments, we found that the T cell I-Ek, as measured by the T cell dose response, would
dose response to peptide presented by freshly fixed be observed. In contrast, if all active I-Ek on the cell
APCs was identical to that of the APCs left for 1±2 days surface is formed by dissociation of endogenous pep-
in the absence of peptide (data not shown). This is con- tides and inactive I-Ek does not reactivate, no effect of
sistent with the previous finding that a nearly stable level reducing the inactive pool would be observed.
of class II peptide binding capacity is maintained when The amount of inactive I-Ek on the cell surface was
either purified MHC or fixed APCs are incubated in the reduced by loading all empty I-Ek formed by dissocia-
absence of peptide (Jensen, 1990, 1991). tion of endogenous peptides with a peptide that binds
The first peptide preloading experiment with fixed stably to I-Ek, preventing it from forming the inactive,
APCs tested whether dissociation of peptide from the empty molecule. The rationally designed peptide used
cell surface I-Ek results in active I-Ek. The design of in these experiments, which we term binds Ek peptide
the experiment was analogous to the experiment with (BEK), has a dissociation half-time .200 hr from I-Ek
purified sEk in Figures 2B and 6A, where the effect of (data not shown) but has no similarity to MCC at its T
preloading sEk with the mutated CLIP peptide M90L cell receptor contacts (see Experimental Procedures).
M98L was measured. The mutated CLIP peptide was It therefore should only affect MCC-specific T cell stimu-
used instead of wild-type CLIP, because the APCs are lation by MHC blockade. Pretreatment of fixed CH27
left in the absence of peptide at pH 7.0 during the set- cells with the BEK peptide results in an approximately
up of the experiment (approximately 40 min), and wild- 3-fold reduction in the amount of active I-Ek on the cell
type CLIP would have dissociated greatly during that surface as measured by the T cell dose response (data
time. As shown in Figure 7A, preloading of the fixed not shown). This reduction is maintained even if BEK is
CH27 cells with mutated CLIP peptide results in an en- washed away 100 min prior to use of the APCs (Figure
hancement of the acid release response to MCC pep- 7D). This delay is sufficient for most of the active I-Ek
tide. The data in Figure 7A are summarized in Figure on the cell surface to inactivate, as the half-life of the
7B, which shows the acid release response versus the active I-Ek molecule is ,40 min. Therefore, the BEK
log of the MCC peptide concentration added. The plot treatment cannot directly reduce the amount of active
shows that 10-fold less MCC is needed when presented I-Ek by binding to it. Instead, it must reduce the amount
by APCs pretreated with the mutated CLIP peptide ver- of active I-Ek by decreasing the pool of inactive mole-
sus those pretreated in the absence of peptide. Based cules that can reactivate. Thus, the steady level of active
on equation I, this implies that the mutated CLIP treated I-Ek on the surface of a fixed APC is maintained by a
APCs have 10-fold more active I-Ek on their surface slow reactivation of inactive, empty I-Ek, as well as by
than the no peptide treated APCs (see Experimental dissociation of endogenous peptide/I-Ek complexes.
Procedures). Therefore, dissociation of preformed pep-
tide/MHC complex results in active, cell surface I-Ek. Experimental Procedures
This may explain why some peptides that bind weakly
to class II MHC augment T cell responses to other, unre- MHC Proteins and Peptides
Soluble I-Ek was expressed as glycosylphosphatidylinositol-anchoredlated peptides (Feng and Lai, 1994).
molecules in Chinese hamster ovary cells, affinity purified as de-The stability of the active, cell surface I-Ek was investi-
scribed (Wettstein et al., 1991; Reay et al., 1992), further purifiedgated by allowing fixed CH27 cells preloaded with the
by high performance size exclusion chromatography (HPSEC), and
mutated CLIP peptide to incubate in the absence of stored at 48C prior to use. The duration of storage at 48C (up to 1
peptide at pH 5.3, 378C for 1 hr. This treatment results year) did not affect the peptide binding kinetics (data not shown).
Soluble DR1, expressed by S2 cell transformants, affinity purifiedin a decrease in the amount of active I-Ek on the cell
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as described (Sloan et al., 1995), and stored at 2708C until use was
the kind gift of Betsy Mellins and Dennis Zaller.
All peptides in this report were synthesized by standard FMOC
chemistry, purified by HPLC, and checked for identity and purity by
mass spectrometry. The peptides sequences were the following:
MCC Ac95-103 (AcIAYLKQATK); MCC 95-103 (IAYLKQATK); MCC
Ac96-103 ª8-merº (AcAYLKQATK); Ii 85-99 ªCLIPº (KPVSQMRMATP
LLMR); Ii 85-99 M90L M98L ªCLIP M90L M98Lº (KPVSQLRMATPLL
LR); HA 306-318 (PKYVKQNTLKLAT); BEK (ANERADLISYTTQADK).
Ac represents an acetyl group; the other letters are standard one
letter abbreviations for the amino acids. The 8-mer peptide binds
to I-Ek in the same register as full-length MCC, as it can stimulate
cytokine production by MCC-specific T cells (J. R., unpublished
results; Schwartz et al., 1985). The 8-mer peptide also likely binds
in the groove of sDR1, as its binding to sDR1 is blocked by addition
of unlabeled HA (data not shown). The BEK peptide sequence was
designed based on the I-Ek binding motif described by Reay et al.
(1994). It is identical to MCC 88-103 except for mutations at the p2,
p5, and p8 T cell receptor contacts (A96S, K99T, and T102D) and
the p4 residue (L98T).
Peptide labeling was performed as follows: all peptides except
MCC Ac95-103 and MCC Ac96-103 were labeled while on the resin
by reaction of their free N termini with 5-(and 6-)carboxyfluorescein
succinimidyl ester in DMSO with a catalytic amount of diisopropyl-
ethylamine. MCC Ac95-103 and MCC Ac96-103 were labeled at their
C termini as follows: in the standard FMOC synthesis, an additional
C-terminal amino acid was added, N-a-Fmoc-N-e-1-(4,4,-dimethyl-
2,6-dioxocyclohex-1-ylidene)ethyl-L-lysine (Novabiochem). This re-
sulted in a resin-bound peptide with MCC lysine 103 followed at
the C terminus with an additional lysine protected with the -Dde
functionality. With the peptide still on resin and the N terminus
Fmoc protected, the -Dde group was selectively cleaved with 2%
hydrazine in DMF, and carboxyfluorescein was coupled to the
e-amino group of the additional C-terminal lysine as described
above.
Peptide±MHC Reaction Kinetics
Labeled peptide and class II MHC were incubated together in PBS
(150 mM sodium chloride, 10 mM sodium phosphate, and 0.02%
sodium azide) at pH 7.0, or PBS containing 100 mM sodium citrate
at pH 5.3. Complex association was measured by taking an aliquot
from the peptide±MHC mixture and separating free peptide from
peptide/MHC complex by passage down a spin column (small scale
Sephadex G50-SF size exclusion column pretreated with 10 mg/mL
BSA solution for .10 hr to minimize nonspecific binding to the
column; similar results were also obtained with spin columns
blocked with reconstituted nonfat dried milk) at 48C, pH 7.0. The
eluted peptide/MHC complex was then further purified by HPSEC
Data points represent the percent increase in acid release rate 12
min after addition of MCC peptide. The line indicates a log-linear
fit to the data. The label ª12.6-foldº indicates that a 12.6-fold greater
concentration of peptide was required to produce a given level of
acid release using the no peptide treated APCs as compared to the
mutated CLIP treated APCs. Similar results were obtained in three
independent experiments.
(C) Formation of active I-Ek by peptide/MHC complex dissociation
is followed by rapid I-Ek inactivation. Fixed CH27 cells were incu-
bated at pH 5.3, 378C for 20 hr in the presence of 200 mM CLIP M90L
M98L. The APCs were then washed and incubated for additional 60
min, under the same conditions, in either the presence or absence
Figure 7. T Cell Stimulation by Fixed APCs Preloaded with Various of 200 mM of this peptide, and T cell stimulation was measured as
Peptides described above. Incubation of the APCs in the absence of peptide
(A) Enhanced T cell acid release by APCs preloaded with a peptide for 60 min resulted in a $3-fold shift in the T cell dose response in
that rapidly dissociates from I-Ek, CLIP M90L M98L. Fixed CH27 four independent experiments.
cells were incubated at pH 5.3, 378C for 20 hr in either presence or (D) Inactive I-Ek on the cell surface slowly reverts to active I-Ek.
absence of 200 mM of this CLIP mutant. After this time, the APCs Fixed CH27 cells were incubated at pH 5.3, 378C for 30 hr in either
were washed and mixed with 5C.C7 T cells. The T cells response the presence or absence of a peptide that binds stably to I-Ek, BEK
to a 3 min exposure to the indicated concentration of MCC Ac95- (for details on BEK, see Experimental Procedures). The APCs were
103 peptide was then measured based on increases in the rate of then washed and incubated for additional 100 min, under the same
T cell acid release over the subsequent 9 min. conditions, in the absence of BEK, and T cell stimulation was mea-
(B) Dissociation of a preformed peptide/MHC complex generates sured as described above. Similar results were obtained in three
active I-Ek on the cell surface (summary of data presented in [A]). independent experiments.
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using a 7.5 mm 3 60 cm TSK G3000SW column (Toso Haas, Mont- equation (III). For the fit, the first term in equation (III) was multiplied
by an arbitrary constant to account for the binding units, and t wasgomeryville, PA) with a running buffer of pH 7.0 PBS at 258C. The
flow rate was 1 ml/min. Peptide/MHC complex eluted at 16 min for taken as the delay time plus the 5 min binding time used to measure
[Ma], as dissociation of M/p continues during the binding reaction.sEk complexes and 18 min for sDR1 complexes. The HPSEC column
was connected to a fluorescence detector and a UV detector in
series. Concentrations of fluorescent peptide/MHC complex were Association Rate Constants
The association rate of peptide to active sEk was calculated bydetermined by comparison of the peak height of the complex to the
peak height of known concentrations of carboxyfluorescein. For fitting the data in Figure 4 to the equation
Figures 3B and 4, the aliquot of labeled peptide and MHC was
[p/M](t) 5 [p/M]max (1 2 Exp(2kon ´ [p] ´ t))injected directly onto the HPSEC without initial purification on the
spin column. This was possible because of the low labeled peptide with t 5 3 min and the peptide concentration variable. Analogous
concentrations used in these experiments. experiments performed with [p] 5 50 nM and data points taken at
In many experiments, empty sDR1 or sEk was preloaded with an 1, 2, and 3 min yielded identical association rates.
unlabeled peptide prior to adding the labeled peptide. Preloading The association rate of peptide to active sDR1 was approximated
was for 36 hr at pH 5.3, 378C with 1.2 mM MHC and 200 mM peptide based on the minimal concentration of HA required to fill most sDR1a
(sEk) or 1 mM peptide (sDR1). Following this loading reaction, the formed by 8-mer dissociation (100 nM HA, Figure 4B). As shown in
reaction mixture was stored at pH 5.3, 48C until immediately prior scheme (5) below, sDR1a formed by 8-mer/DR1 complex (8/DR1)
to use, when free peptide was separated from peptide/MHC com- dissociation can react to form sDR1i with the rate constant kin 5
plex by passage down a spin column at 48C, pH 7.0 to isolate the 0.14 min21 known from Figure 5C.
MHC for the subsequent association reaction with labeled peptide.
For measurements of peptide/MHC complex dissociation, labeled
complex was isolated from a mixture of free peptide and MHC using
a spin column as described above. After complex isolation (final
complex concentration ≈ 100 nM MHC), unlabeled peptide (MCC
88±103 or MCC Ac95±103 for sEk, HA 306±318 for sDR1) was added
to 10 mM final concentration to prevent rebinding of labeled peptide,
citrate was added for dissociation reactions at pH 5.3, and the
complex was placed at 378C. After the indicated time, complex Alternatively, sDR1a can react with HA to form HA/sDR1 with the
was injected on the HPSEC apparatus, and the amount of labeled rate constant kon [HA]. As shown in Figure 5B, 100 nM HA is sufficient
peptide/MHC complex remaining was measured based on the for slightly more than half of the sDR1a to bind HA rather than
height of the fluorescence signal. inactivate. Thus kon ´ 100 nM ≈ 0.14 min21, which implies that kon ≈
3 3 104 M21 s21.
Inactivation Rate Constants
The inactivation rate of active sEk and sDR1 was computed using Amount of Active I-Ek on the Surface of an APC
the data shown in Figures 3A and 5C. For these computations, we Estimation of the amount of active I-Ek on the surface of an APC
assume the validity of reaction scheme (4) shown below. is based on T cell acid release measurements with 5C.C7 T cells
and CH27 APCs performed as previously described (Rabinowitz et
al., 1996). When indicated in the text, CH27 cells were fixed with
0.1% glutaraldehyde in PBS (pH 7.4), 378C for 2 min, followed by
immediate addition of a 2-fold volume excess of DMEM 0.2 M
L-lysine. The fixed CH27 cells were then washed once in RPMI
medium 1640 with 10% fetal calf serum prior to use.
Similar to previous work (Beeson et al., 1996), we observe that
the acid release response to peptide over a broad range of peptidep/M is a preformed peptide/MHC complex with dissociation rate
concentrations can be related to the log of the peptide concentrationkoff; Ma and Mi are active and inactive class II (either sDR1 or sEk);
added (Figure 7). This suggests that the number of peptide/I-Ekkin is the rate of inactivation of Ma; kac is the rate of formation of Ma
complexes per APC ([p/Ek]) and the T cell acid release responsefrom Mi. This scheme is identical to scheme (3) except that we
(A) can be related by the following equation:assume no free peptide is present. The differential equations corre-
sponding to scheme (4) are the following: A([p/Ek]) 5 C1 1 C2 log [p/Ek] (IV)
where the constants C1 and C2 depend on the peptide, the T cells,d[p/M]
dt
5 2koff[p/M] (IIa)
and the APCs, but not on the APC preloading.
As described in the Appendix, we also find that for 100 nM #d[Ma]
dt
5 koff[p/M] 2 kin[Ma] 1 kac[Mi] (IIb) [MCC] # 3 mM,
[p/Ek] 5 kon ´ t ´ [p] ´ [Eka] (I)d[Mi]
dt
5 kin[Ma] 2 kac[Mi] (IIc)
Combining the above, we get
A ([p/Ek]) 5 A(kon ´ t ´ [p] ´ [Eka])This system of equations can be simplified if the formation of Ma
from Mi is assumed to be either (i) low relative to the formation of
5 C1 1 C2 log ([kon ´ t ´ [p] ´ [Eka])Ma from p/M (which is true for sEk; Figure 3A and additional data
not shown) or (ii) approximately constant with respect to time (which 5 C1 1 C2 log [kon ´ t ´ p0] 1 C2 log[ Eka] 1 C2 log [p/p0]
is true for sDR1, Figure 5 and additional data not shown). Based on
where p0 is an arbitrary, fixed peptide concentration (1 mM) neededthese assumptions, equations IIa and IIb can be solved analytically
for each of the terms under the logarithm function to be dimen-for [Ma] as a function of time with kac 5 0 to give the equation
sionless. For a fixed APC pretreatment (i.e., fixed [Eka]), this implies




(Exp(2koff ´ t) 2 Exp(2kin ´ t)) 1 C (III) tion of peptide added by the equation:
A ([p]) 5 C3 1 C4 1 C2 log [p/p0]where C is a constant added to represent the plateau binding level
after long delay times (C 5 0.2 for 8-mer/Ek, Figure 3A; C 5 0.4 for where C3 5 C1 1 C2 log [kon ´ t ´ p0] and C4 5 C2 log [Eka] (V)8-mer/DR1, Figure 5C). koff can be directly measured based on the
data shown in 2C and 5B (koff 5 0.14 min21 for 8-mer/Ek; koff 5 0.033 The lines in Figures 7B, 7C, and 7D indicate the best fit to the
experimental data using equation (V). Note that the X intercept (i.e.,min21 for 8-mer/DR1). kin was calculated by obtaining the best fit to
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[p]* such that A([p]*) 5 0) of the log-linear fit is given by the following: major histocompatibility molecule augments T cell responses. Eur.
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